Canopy Growth (CGC) Other financing activities (2019 - 2025)
Canopy Growth (CGC) reported Other financing activities of -$8.6 million for Q2 2025, down 160.82% on a YoY basis from $14.1 million in Q2 2024, and up 40.25% sequentially from -$14.4 million in Q4 2024.
Canopy Growth (CGC) Other financing activities (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Other financing activities data on file, last reported at -$8.6 million in Q2 2025.
- For the quarter ending Q2 2025, Other financing activities fell 160.82% year-over-year to -$8.6 million; the trailing twelve-month figure through Dec 2025 stood at -$19.6 million (down 428.72% YoY), and the FY2025 full-year result was -$16.5 million, changed N/A from the prior year.
- Other financing activities improved to -$8.6 million in Q2 2025, from -$14.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $20.2 million in Q1 2024 to a low of -$28.3 million in Q1 2023.
- A 5-year average of -$3.2 million and a median of -$2.1 million in 2021 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities sank 4429.23% in 2022 and jumped 171.4% in 2024, its largest moves.
- Tracing CGC's Other financing activities over 5 years: stood at $6.7 million in 2021, then surged by 46.4% to $9.9 million in 2022, then plunged by 109.91% to -$977666.8 in 2023, then tumbled by 1368.43% to -$14.4 million in 2024, then soared by 40.25% to -$8.6 million in 2025.
- Business Quant data shows CGC's Other financing activities at -$8.6 million in Q2 2025, -$14.4 million in Q4 2024, and $3.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -8.58 Mn |
| Jun 30, 2025 | -8.58 Mn |
| Dec 31, 2024 | -14.36 Mn |
| Dec 31, 2024 | -14.36 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | 20.21 Mn |
| Mar 31, 2024 | 20.21 Mn |
| Dec 31, 2023 | -977,666.79 |
| Dec 31, 2023 | -977,666.79 |
| Sep 30, 2023 | -8.26 Mn |
| Sep 30, 2023 | -8.26 Mn |
| Jun 30, 2023 | -11.04 Mn |
| Jun 30, 2023 | -11.04 Mn |
| Mar 31, 2023 | -28.31 Mn |
| Mar 31, 2023 | -28.31 Mn |
| Dec 31, 2022 | 9.86 Mn |
| Dec 31, 2022 | 9.86 Mn |